Report Overview
Artificial Intelligence (AI) has emerged as a powerful tool in the fight against novel coronavirus (COVID-19) and other epidemics. AI refers to the simulation of human intelligence processes by machines, including learning, reasoning, and self-correction. In the context of COVID-19 and epidemics, AI is being utilized for various purposes such as disease detection, drug discovery, contact tracing, and forecasting.
The market for AI in combating COVID-19 and epidemics is characterized by rapid growth and innovation. Key growth drivers include the need for accurate and timely disease detection, the urgency to develop effective treatments and vaccines, and the demand for efficient public health interventions. Market forces such as increased investment in healthcare technology, collaborations between tech companies and healthcare institutions, and government support for AI research further propel the market forward.
One of the prominent trends in the market is the use of AI for early detection and diagnosis of diseases. For example, AI-powered systems can analyze medical imaging scans to identify COVID-19-related patterns in the lungs, enabling faster diagnosis and treatment. This trend is supported by the increasing availability of healthcare data and advancements in machine learning algorithms.
Another trend is the application of AI in drug discovery and development. Pharmaceutical companies are leveraging AI to accelerate the process of identifying potential drug candidates, predicting their efficacy, and optimizing clinical trials. For instance, AI algorithms can analyze vast amounts of biological data to identify existing drugs that could be repurposed for treating COVID-19.
Furthermore, AI is playing a crucial role in contact tracing efforts during epidemics. By analyzing data from smartphones, wearables, and other sources, AI algorithms can track the movement of individuals, identify potential exposure to the virus, and provide recommendations for testing and isolation. This trend is exemplified by the use of AI-powered contact tracing apps in various countries to contain the spread of COVID-19.
Overall, the market for AI in combating COVID-19 and epidemics is driven by the need for innovative solutions to public health challenges. As AI technologies continue to evolve and mature, they are expected to play an increasingly important role in disease prevention, detection, and response. Stakeholders in the healthcare and technology sectors should continue to invest in AI research and development to harness the full potential of these technologies in safeguarding public health.
The global AI to Novel Coronavirus (COVID-19) and Epidemic market size was estimated at USD 1.60 million in 2024 and is projected to reach USD 1.60 million by 2033, exhibiting a CAGR of 0 during the forecast period.
This report provides a deep insight into the global AI to Novel Coronavirus (COVID-19) and Epidemic market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter's five forces analysis, value chain analysis, PEST analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global AI to Novel Coronavirus (COVID-19) and Epidemic Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the AI to Novel Coronavirus (COVID-19) and Epidemic market in any manner.
Global AI to Novel Coronavirus (COVID-19) and Epidemic Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Google
Alibaba
Artificial Intelligence in Medical Epidemiology
BlueDot
Beijing Infervision Technology Co.
Ltd.
BenevolentAI
SenseTime
Insilico Medicine
DEARGEN
Iktos
SRI Biosciences
Market Segmentation (by Type)
AI Tracking
AI Predict
AI Recognition
Other
Market Segmentation (by Application)
Medical
Public Emergency
Other
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the AI to Novel Coronavirus (COVID-19) and Epidemic Market
- Overview of the regional outlook of the AI to Novel Coronavirus (COVID-19) and Epidemic Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the AI to Novel Coronavirus (COVID-19) and Epidemic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of AI to Novel Coronavirus (COVID-19) and Epidemic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
Table of Contents 1 Research Methodology and Statistical Scope 1.1 Market Definition and Statistical Scope of AI to Novel Coronavirus (COVID-19) and Epidemic 1.2 Key Market Segments 1.2.1 AI to Novel Coronavirus (COVID-19) and Epidemic Segment by Type 1.2.2 AI to Novel Coronavirus (COVID-19) and Epidemic Segment by Application 1.3 Methodology & Sources of Information 1.3.1 Research Methodology 1.3.2 Research Process 1.3.3 Market Breakdown and Data Triangulation 1.3.4 Base Year 1.3.5 Report Assumptions & Caveats 2 AI to Novel Coronavirus (COVID-19) and Epidemic Market Overview 2.1 Global Market Overview 2.1.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (M USD) Estimates and Forecasts (2020-2033) 2.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales Estimates and Forecasts (2020-2033) 2.2 Market Segment Executive Summary 2.3 Global Market Size by Region 3 AI to Novel Coronavirus (COVID-19) and Epidemic Market Competitive Landscape 3.1 Company Assessment Quadrant 3.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Product Life Cycle 3.3 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Manufacturers (2020-2025) 3.4 Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Manufacturers (2020-2025) 3.5 AI to Novel Coronavirus (COVID-19) and Epidemic Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.6 Global AI to Novel Coronavirus (COVID-19) and Epidemic Average Price by Manufacturers (2020-2025) 3.7 Manufacturers AI to Novel Coronavirus (COVID-19) and Epidemic Sales Sites, Area Served, Product Type 3.8 AI to Novel Coronavirus (COVID-19) and Epidemic Market Competitive Situation and Trends 3.8.1 AI to Novel Coronavirus (COVID-19) and Epidemic Market Concentration Rate 3.8.2 Global 5 and 10 Largest AI to Novel Coronavirus (COVID-19) and Epidemic Players Market Share by Revenue 3.8.3 Mergers & Acquisitions, Expansion 4 AI to Novel Coronavirus (COVID-19) and Epidemic Industry Chain Analysis 4.1 AI to Novel Coronavirus (COVID-19) and Epidemic Industry Chain Analysis 4.2 Market Overview of Key Raw Materials 4.3 Midstream Market Analysis 4.4 Downstream Customer Analysis 5 The Development and Dynamics of AI to Novel Coronavirus (COVID-19) and Epidemic Market 5.1 Key Development Trends 5.2 Driving Factors 5.3 Market Challenges 5.4 Market Restraints 5.5 Industry News 5.5.1 New Product Developments 5.5.2 Mergers & Acquisitions 5.5.3 Expansions 5.5.4 Collaboration/Supply Contracts 5.6 PEST Analysis 5.6.1 Industry Policies Analysis 5.6.2 Economic Environment Analysis 5.6.3 Social Environment Analysis 5.6.4 Technological Environment Analysis 5.7 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Porter's Five Forces Analysis 5.7.1 Global Trade Frictions 5.7.2 Global Trade Frictions and Their Impacts to AI to Novel Coronavirus (COVID-19) and Epidemic Market 5.8 ESG Ratings of Leading Companies 6 AI to Novel Coronavirus (COVID-19) and Epidemic Market Segmentation by Type 6.1 Evaluation Matrix of Segment Market Development Potential (Type) 6.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales Market Share by Type (2020-2025) 6.3 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Type (2020-2025) 6.4 Global AI to Novel Coronavirus (COVID-19) and Epidemic Price by Type (2020-2025) 7 AI to Novel Coronavirus (COVID-19) and Epidemic Market Segmentation by Application 7.1 Evaluation Matrix of Segment Market Development Potential (Application) 7.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Sales by Application (2020-2025) 7.3 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (M USD) by Application (2020-2025) 7.4 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales Growth Rate by Application (2020-2025) 8 AI to Novel Coronavirus (COVID-19) and Epidemic Market Sales by Region 8.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Region 8.1.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Region 8.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales Market Share by Region 8.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region 8.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region 8.2.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Market Share by Region 8.3 North America 8.3.1 North America AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Country 8.3.2 North America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country 8.3.3 U.S. Market Overview 8.3.4 Canada Market Overview 8.3.5 Mexico Market Overview 8.4 Europe 8.4.1 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Country 8.4.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country 8.4.3 Germany Market Overview 8.4.4 France Market Overview 8.4.5 U.K. Market Overview 8.4.6 Italy Market Overview 8.4.7 Spain Market Overview 8.5 Asia Pacific 8.5.1 Asia Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Region 8.5.2 Asia Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region 8.5.3 China Market Overview 8.5.4 Japan Market Overview 8.5.5 South Korea Market Overview 8.5.6 India Market Overview 8.5.7 Southeast Asia Market Overview 8.6 South America 8.6.1 South America AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Country 8.6.2 South America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Country 8.6.3 Brazil Market Overview 8.6.4 Argentina Market Overview 8.6.5 Columbia Market Overview 8.7 Middle East and Africa 8.7.1 Middle East and Africa AI to Novel Coronavirus (COVID-19) and Epidemic Sales by Region 8.7.2 Middle East and Africa AI to Novel Coronavirus (COVID-19) and Epidemic Market Size by Region 8.7.3 Saudi Arabia Market Overview 8.7.4 UAE Market Overview 8.7.5 Egypt Market Overview 8.7.6 Nigeria Market Overview 8.7.7 South Africa Market Overview 9 AI to Novel Coronavirus (COVID-19) and Epidemic Market Production by Region 9.1 Global Production of AI to Novel Coronavirus (COVID-19) and Epidemic by Region(2020-2025) 9.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Revenue Market Share by Region (2020-2025) 9.3 Global AI to Novel Coronavirus (COVID-19) and Epidemic Production, Revenue, Price and Gross Margin (2020-2025) 9.4 North America AI to Novel Coronavirus (COVID-19) and Epidemic Production 9.4.1 North America AI to Novel Coronavirus (COVID-19) and Epidemic Production Growth Rate (2020-2025) 9.4.2 North America AI to Novel Coronavirus (COVID-19) and Epidemic Production, Revenue, Price and Gross Margin (2020-2025) 9.5 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Production 9.5.1 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Production Growth Rate (2020-2025) 9.5.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Production, Revenue, Price and Gross Margin (2020-2025) 9.6 Japan AI to Novel Coronavirus (COVID-19) and Epidemic Production (2020-2025) 9.6.1 Japan AI to Novel Coronavirus (COVID-19) and Epidemic Production Growth Rate (2020-2025) 9.6.2 Japan AI to Novel Coronavirus (COVID-19) and Epidemic Production, Revenue, Price and Gross Margin (2020-2025) 9.7 China AI to Novel Coronavirus (COVID-19) and Epidemic Production (2020-2025) 9.7.1 China AI to Novel Coronavirus (COVID-19) and Epidemic Production Growth Rate (2020-2025) 9.7.2 China AI to Novel Coronavirus (COVID-19) and Epidemic Production, Revenue, Price and Gross Margin (2020-2025) 10 Key Companies Profile 10.1 Google 10.1.1 Google Basic Information 10.1.2 Google AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.1.3 Google AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.1.4 Google Business Overview 10.1.5 Google SWOT Analysis 10.1.6 Google Recent Developments 10.2 Alibaba 10.2.1 Alibaba Basic Information 10.2.2 Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.2.3 Alibaba AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.2.4 Alibaba Business Overview 10.2.5 Alibaba SWOT Analysis 10.2.6 Alibaba Recent Developments 10.3 Artificial Intelligence in Medical Epidemiology 10.3.1 Artificial Intelligence in Medical Epidemiology Basic Information 10.3.2 Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.3.3 Artificial Intelligence in Medical Epidemiology AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.3.4 Artificial Intelligence in Medical Epidemiology Business Overview 10.3.5 Artificial Intelligence in Medical Epidemiology SWOT Analysis 10.3.6 Artificial Intelligence in Medical Epidemiology Recent Developments 10.4 BlueDot 10.4.1 BlueDot Basic Information 10.4.2 BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.4.3 BlueDot AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.4.4 BlueDot Business Overview 10.4.5 BlueDot Recent Developments 10.5 Beijing Infervision Technology Co. 10.5.1 Beijing Infervision Technology Co. Basic Information 10.5.2 Beijing Infervision Technology Co. AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.5.3 Beijing Infervision Technology Co. AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.5.4 Beijing Infervision Technology Co. Business Overview 10.5.5 Beijing Infervision Technology Co. Recent Developments 10.6 Ltd. 10.6.1 Ltd. Basic Information 10.6.2 Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.6.3 Ltd. AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.6.4 Ltd. Business Overview 10.6.5 Ltd. Recent Developments 10.7 BenevolentAI 10.7.1 BenevolentAI Basic Information 10.7.2 BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.7.3 BenevolentAI AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.7.4 BenevolentAI Business Overview 10.7.5 BenevolentAI Recent Developments 10.8 SenseTime 10.8.1 SenseTime Basic Information 10.8.2 SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.8.3 SenseTime AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.8.4 SenseTime Business Overview 10.8.5 SenseTime Recent Developments 10.9 Insilico Medicine 10.9.1 Insilico Medicine Basic Information 10.9.2 Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.9.3 Insilico Medicine AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.9.4 Insilico Medicine Business Overview 10.9.5 Insilico Medicine Recent Developments 10.10 DEARGEN 10.10.1 DEARGEN Basic Information 10.10.2 DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.10.3 DEARGEN AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.10.4 DEARGEN Business Overview 10.10.5 DEARGEN Recent Developments 10.11 Iktos 10.11.1 Iktos Basic Information 10.11.2 Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.11.3 Iktos AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.11.4 Iktos Business Overview 10.11.5 Iktos Recent Developments 10.12 SRI Biosciences 10.12.1 SRI Biosciences Basic Information 10.12.2 SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Product Overview 10.12.3 SRI Biosciences AI to Novel Coronavirus (COVID-19) and Epidemic Product Market Performance 10.12.4 SRI Biosciences Business Overview 10.12.5 SRI Biosciences Recent Developments 11 AI to Novel Coronavirus (COVID-19) and Epidemic Market Forecast by Region 11.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast 11.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Forecast by Region 11.2.1 North America Market Size Forecast by Country 11.2.2 Europe AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Country 11.2.3 Asia Pacific AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Region 11.2.4 South America AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Country 11.2.5 Middle East and Africa Forecasted Sales of AI to Novel Coronavirus (COVID-19) and Epidemic by Country 12 Forecast Market by Type and by Application (2026-2033) 12.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Forecast by Type (2026-2033) 12.1.1 Global Forecasted Sales of AI to Novel Coronavirus (COVID-19) and Epidemic by Type (2026-2033) 12.1.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size Forecast by Type (2026-2033) 12.1.3 Global Forecasted Price of AI to Novel Coronavirus (COVID-19) and Epidemic by Type (2026-2033) 12.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Forecast by Application (2026-2033) 12.2.1 Global AI to Novel Coronavirus (COVID-19) and Epidemic Sales (K Units) Forecast by Application 12.2.2 Global AI to Novel Coronavirus (COVID-19) and Epidemic Market Size (M USD) Forecast by Application (2026-2033) 13 Conclusion and Key Findings
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook